Both in Pharmaceuticals
Xilio Therapeutics vs Clene
Over the past year XLO returned −26.0% and CLNN returned −31.6%; their daily moves had a correlation of -0.02.
XLO −26.0% CLNN −31.6%Growth of $1, one year, split-adjusted
| Metric | XLO | CLNN |
|---|---|---|
| Price | $8.94 | $4.10 |
| Market cap | $58.8M | $58.3M |
| Today | −1.24% | +0.99% |
| 1 month | −0.7% | −3.1% |
| 6 months | +8.5% | −14.9% |
| Year to date | −0.3% | −30.2% |
| 1 year | −19.8% | −30.3% |
| Revenue growth (YoY) | +131.2% | +233.3% |
| Gross margin | 100.0% | 60.0% |
| Net margin | −34.1% | −14915.6% |
| P/E (TTM) | — | — |
| Price / sales | 0.9× | 295.8× |
| Net cash | $136.0M | -$9.1M |
| Dividend yield | — | — |
| Volatility (60d) | 23.1% | 79.3% |
| Short % of float | 10.4% | 11.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).